Shockwave Medical Inc (SWAV)
329.55
-0.45
(-0.14%)
USD |
NASDAQ |
Apr 29, 11:14
Shockwave Medical Profit Margin (Quarterly): 21.83% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 21.83% |
September 30, 2023 | 18.81% |
June 30, 2023 | 16.02% |
March 31, 2023 | 24.29% |
December 31, 2022 | 97.84% |
September 30, 2022 | 26.65% |
June 30, 2022 | 21.17% |
March 31, 2022 | 15.51% |
December 31, 2021 | 15.37% |
September 30, 2021 | 2.99% |
June 30, 2021 | -0.76% |
March 31, 2021 | -73.98% |
Date | Value |
---|---|
December 31, 2020 | -69.88% |
September 30, 2020 | -66.01% |
June 30, 2020 | -176.1% |
March 31, 2020 | -123.5% |
December 31, 2019 | -103.0% |
September 30, 2019 | -114.3% |
June 30, 2019 | -106.0% |
March 31, 2019 | -176.1% |
December 31, 2018 | -221.7% |
September 30, 2018 | -282.7% |
June 30, 2018 | -443.5% |
March 31, 2018 | -725.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-176.1%
Minimum
Jun 2020
97.84%
Maximum
Dec 2022
-30.17%
Average
2.99%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 12.81% |
AtriCure Inc | -9.19% |
Masimo Corp | 6.18% |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | -15.31% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 24.80% |
Return on Assets | 14.01% |
Return on Invested Capital | 16.06% |
Gross Profit Margin (Quarterly) | 87.53% |
Operating Margin (Quarterly) | 21.32% |
Return on Net Operating Assets | 41.62% |